MedPath

Horse chestnut

Generic Name
Horse chestnut
Drug Type
Biotech
Unique Ingredient Identifier
3C18L6RJAZ

Overview

Horse chestnut is a flowering plant commonly referred to as Aesculus hippocastanum. Unprocessed horse chestnut seeds contain a toxin called esculin (also spelled aesculin) that increases the risk of bleeding due to anticoagulant actions. These seeds are processed to remove the toxic component, resulting in purified horse chestnut seed extract (HCSE) . The active component of this pure extract is escin, or aescin, that promotes blood circulation through the veins and reduces swelling and inflammation of the legs. Its therapeutic potential in the treatment of chronic venous insufficiency is being studied.

Indication

No indication information available.

Associated Conditions

  • Back Pain Lower Back
  • Back pain
  • Cervical Syndrome
  • Contusions
  • Haemorrhoids
  • Sciatica
  • Thrombophlebitis
  • Trigger Finger Disorder
  • Vessels; Varicose
  • Hematomas

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor

No clinical trials found

No clinical trials found for this drug

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
King Bio Inc.
57955-6031
ORAL
10 [hp_X] in 59 mL
5/23/2025
King Bio Inc.
57955-2822
ORAL
10 [hp_X] in 59 mL
5/20/2025
King Bio Inc.
57955-6163
ORAL
10 [hp_X] in 59 mL
5/19/2025

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
AESCULUS COMPOSÉ
dolisos canada inc.
02236447
Cream ,  Ointment - Topical
1 X
1/5/1998
CUTISITUM
02236489
Liquid - Oral
6 D
2/6/1998
SEPIA COMPOSE DPS
laboratoires holis inc.
01934422
Drops - Oral
3 DH / DH
12/31/1984
POMMADE MIDY
welcker-lyster ltd., division of technilab inc.
00292591
Ointment - Rectal
2.5 G / 100 G
12/31/1948
AESCULUS HIPPOCASTANUM
dolisos canada inc.
02234281
Granules ,  Globules ,  Liquid - Oral
1 X
1/5/1998
THROAT
botanical laboratories inc.
02233409
Tablet - Oral
6 X
4/15/1998
MEDIPLEX 640 - LIQ
mediherb inc.
02116901
Liquid - Oral
6 X / ML
12/19/1996
HP5 TAB
01975870
Tablet - Oral
3 X
10/4/1996
AESCULUS DROPS 1X TO C1000
thompson's homeopathic supplies ltd.
00761567
Drops - Oral
1 X
12/31/1988
AESCULUS COMPOSÉ
dolisos canada inc.
02236442
Globules ,  Granules ,  Liquid - Oral
1 X
1/5/1998

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
CASTAÑO DE INDIAS ARKOPHARMA cápsulas duras
Arkopharma Laboratorios S.A.U.
74480
CÁPSULA DURA
Sin Receta
Not Commercialized

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.